Ecology

Biotechnology

Biology

Small molecule

Biochemistry

Business

Immunology

Competition (biology)

Biosimilar

Monoclonal antibody

Industrial organization

Chemistry

Antibody

Trends in biotechnology

The monoclonal antibody (mAb) market has changed rapidly in the past 5 years: it has doubled in size, becoming dominated by fully human molecules, launched bispecific molecules, and faced competition from biosimilars. We summarize the market in terms of therapeutic applications, type and structure of mAbs, dominant companies, manufacturing locations, and emerging markets.

The Increasingly Human and Profitable Monoclonal Antibody Market